{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:16:00Z","timestamp":1791162960093,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ejphar.2004.04.004","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T01:09:56Z","timestamp":1085792996000},"page":"273-280","source":"Crossref","is-referenced-by-count":53,"title":["Effects of intravenous infusion of highly purified vitamin B 2 on lipopolysaccharide-induced shock and bacterial infection in mice"],"prefix":"10.1016","volume":"492","author":[{"given":"Toshio","family":"Toyosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtarou","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.04.004_BIB1","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/IAI.55.9.2164-2170.1987","article-title":"Enhancement of resistance to Escherichia coli infection in mice by dihydroheptaprenol, a synthetic polyprenol derivative","volume":"55","author":"Araki","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1292\/jvms.57.599","article-title":"Enhancement of resistance to bacterial infection in mice by vitamin B2","volume":"57","author":"Araki","year":"1995","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00003246-199502000-00026","article-title":"An overview of mortality risk prediction in sepsis","volume":"23","author":"Barriere","year":"1995","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00003246-199602000-00003","article-title":"Acute renal failure in intensive care units\u2014causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure","volume":"24","author":"Brivet","year":"1996","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB6","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1182\/blood.V86.10.3841.bloodjournal86103841","article-title":"Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis","volume":"86","author":"Bossink","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2004.04.004_BIB7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2004.04.004_BIB8","doi-asserted-by":"crossref","first-page":"321S","DOI":"10.1378\/chest.112.6_Supplement.321S","article-title":"Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock","volume":"112","author":"Dinarello","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2004.04.004_BIB9","first-page":"347","article-title":"Nitrite\/nitrate oxide (NOx) and cytokine levels in patients with septic shock","volume":"91","author":"Endo","year":"1996","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB10","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/00003246-200107001-00018","article-title":"Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation","volume":"29","author":"Esmon","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB11","first-page":"245","article-title":"Age-related increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI575","article-title":"Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein C reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation","volume":"101","author":"Gresele","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.ph.57.030195.003513","article-title":"Nitric oxide: pathophysiological mechanisms","volume":"57","author":"Gross","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB14","first-page":"368","article-title":"In vitro and in vivo effects of riboflavin sodium phosphate on the phagocytic activity of peritoneal macrophages in mice","volume":"67","author":"Kimura","year":"1996","journal-title":"Anim. Sci. Technol."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd1153","article-title":"Therapeutic approaches to innate immunity: severe sepsis and septic shock","volume":"2","author":"Lolis","year":"2003","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00003246-199404000-00025","article-title":"Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin","volume":"22","author":"Marty","year":"1994","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1034\/j.1600-065x.2001.1840123.x","article-title":"Regulation of inflammatory responses by natural anticoagulants","volume":"184","author":"Okajima","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1292\/jvms.57.493","article-title":"Effects of vitamin B2 on neutrophil functions in cattle","volume":"57","author":"Osame","year":"1995","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","article-title":"Pathogenetic mechanisms of septic shock","volume":"328","author":"Parrillo","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI112902","article-title":"Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon","volume":"79","author":"Taylor","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB21","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/IAI.72.3.1820-1823.2004","article-title":"Highly purified vitamin B2 presents a promising therapeutic strategy for sepsis and septic shock","volume":"72","author":"Toyosawa","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB22","first-page":"75","article-title":"Studies of the toxicity and pharmacology of riboflavin","volume":"76","author":"Unna","year":"1942","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.04.004_BIB23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ajcn\/63.1.54","article-title":"Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans","volume":"63","author":"Zempleni","year":"1996","journal-title":"Am. J. Clin. Nutr."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904003796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904003796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:49:34Z","timestamp":1585802974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904003796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":23,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0014299904003796"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.04.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}